In a commentary for APM's Marketplace, Dr. Stefan Kertesz questions the current process of approving new drugs, especially when researchers who set health care guidelines also have financial interests in pharmaceutical companies. He cites the timing of the National Cholesterol Education Panel's announcement on recommended cholesterol levels and the drug Vytorin's release to illustrate the need for reform.
is a publication by Science in Society, a Northwestern University research center for science outreach and public engagement.
Scientific research generates new understanding and innovation – but it can also yield unexpected, often breathtaking, beauty. This contest, and its subsequent exhibitions pique curiosity, providing new gateways into research and creative opportunities for diverse communities to connect to and explore Northwestern’s...
Add new comment